Articles dans des revues avec comité de lecture (127)

  1. 106. Eeckman, F., Moës, A., & Amighi, K. (2004). Synthesis and characterization of thermosensitive copolymers for oral controlled drug delivery. European Polymer Journal, 40(4), 873-881. doi:10.1016/j.eurpolymj.2003.11.010
  2. 107. Eeckman, F., Moës, A., & Amighi, K. (2004). Poly(N-isopropylacrylamide) copolymers for constant temperature controlled drug delivery. International journal of pharmaceutics, 273(1-2), 109-119. doi:10.1016/j.ijpharm.2003.12.013
  3. 108. Hamdani, J., Moes, A. J., & Amighi, K. (2003). Physical and thermal characterisation of Precirol® and Compritol® as lipophilic glycerides used for the preparation of controlled-release matrix pellets. International journal of pharmaceutics, 260(1), 47-57. doi:10.1016/S0378-5173(03)00229-1
  4. 109. Eeckman, F., Moës, A., & Amighi, K. (2003). Surfactant induced drug delivery based on the use of thermosensitive polymers. Journal of controlled release, 88(1), 105-116. doi:10.1016/S0168-3659(02)00457-1
  5. 110. Semde, R., Moes, A. J., Devleeschouwer, M., & Amighi, K. (2003). Synthesis and enzymatic degradation of epichlorohydrin cross-linked pectins. Drug development and industrial pharmacy, 29(2), 203-213. doi:10.1081/DDC-120016728
  6. 111. Hamdani, J., Moes, A. J., & Amighi, K. (2002). Development and evaluation of prolonged release pellets obtained by the melt pelletization process. International journal of pharmaceutics, 245(1-2), 167-177. doi:10.1016/S0378-5173(02)00348-4
  7. 112. Semde, R., Moës, A., Devleeschouwer, M., & Amighi, K. (2002). In vitro evaluation of epichlorohydrin cross-linked pectins as colon-specific drug delivery carriers. S.T.P. Pharma Sciences, 12(5), 293-298.
  8. 113. Eeckman, F., Moës, A., & Amighi, K. (2002). Evaluation of a new controlled-drug delivery concept based on the use of thermoresponsive polymers. International journal of pharmaceutics, 241(1), 113-125. doi:10.1016/S0378-5173(02)00198-9
  9. 114. Eeckman, F., Amighi, K., & Moës, A. (2001). Effect of some physiological and non-physiological compounds on the phase transition temperature of thermoresponsive polymers intended for oral controlled-drug delivery. International journal of pharmaceutics, 222(2), 259-270. doi:10.1016/S0378-5173(01)00716-5
  10. 115. Amighi, K. (2001). Nouvelles recherches sur l'intérêt des polymères en formulation galénique. Bulletin et mémoires de l'Académie royale de médecine de Belgique, 156(6 Pt 2), 302-310.
  11. 116. Semde, R., Amighi, K., Devleeschouwer, M., & Moes, A. J. (2000). Studies of pectin HM/Eudragit® RL/Eudragit® NE film-coating formulations intended for colonic drug delivery. International journal of pharmaceutics, 197(1-2), 181-192. doi:10.1016/S0378-5173(99)00467-6
  12. 117. Semde, R., Amighi, K., Devleeschouwer, M., & Moes, A. J. (2000). Effect of pectinolytic enzymes on the release of theophylline from pellets coated with water insoluble polymers containing pectin HM or calcium pectinate. International journal of pharmaceutics, 197, 169-179. doi:10.1016/S0378-5173(99)00465-2

  13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Suivant >>